Polymorphisms in the Inflammatory Genes CIITA, CLEC16A and IFNG Influence BMD, Bone Loss and Fracture in Elderly Women

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Swanberg, Maria ^a,b   McGuigan, Fiona E ^a   Ivaska, Kaisa K ^c   Gerdhem, Paul ^d,e   Åkesson, Kristina ^a,f  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF TURKU   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C TYPE LECTIN DOMAIN 16A; GAMMA INTERFERON; LECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BONE DENSITY; CIITA GENE; CLEC16A GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC RISK; GENETIC VARIABILITY; GERIATRIC PATIENT; HETEROZYGOSITY; HIP FRACTURE; HOMOZYGOSITY; HUMAN; IFNG GENE; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; OSTEOLYSIS; PATHOGENESIS; PHENOTYPE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; COHORT STUDIES; FEMALE; FEMUR NECK; FRACTURES, BONE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERFERON-GAMMA; LECTINS, C-TYPE; LUMBAR VERTEBRAE; MONOSACCHARIDE TRANSPORT PROTEINS; NUCLEAR PROTEINS; OSTEOGENESIS; OSTEOPOROSIS; POLYMORPHISM, GENETIC; QUESTIONNAIRES; TRANS-ACTIVATORS;

EID: 84868153915     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047964     Document Type: Article

References (76)

1. Cummings SR, Melton LJ, (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359: 1761-1767.
2. Ferrari S, (2008) Human genetics of osteoporosis. Best Pract Res Clin Endocrinol Metab 22: 723-735.
3. Takayanagi H, (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7: 292-304.
4. Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H, (2007) Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 18: 251-259.
5. Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, et al. (2006) Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17: 1065-1077.
6. Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaelsson K, (2007) Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int 18: 1355-1362.
7. Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T, (1985) Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. J Immunol 135: 2562-2568.
8. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, et al. (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408: 600-605.
9. Nagarajan UM, Bushey A, Boss JM, (2002) Modulation of gene expression by the MHC class II transactivator. J Immunol 169: 5078-5088.
10. Steimle V, Otten LA, Zufferey M, Mach B, (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75: 135-146.
11. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, et al. (1994) Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 39: 41-48.
12. Stastny P, (1976) Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 57: 1148-1157.
13. Zanelli E, Breedveld FC, de Vries RR, (2000) HLA class II association with rheumatoid arthritis: facts and interpretations. Hum Immunol 61: 1254-1261.
14. Pattrick M, Manhire A, Ward AM, Doherty M, (1989) HLA-A, B antigens and alpha 1-antitrypsin phenotypes in nodal generalised osteoarthritis and erosive osteoarthritis. Ann Rheum Dis 48: 470-475.
15. Nakajima M, Takahashi A, Kou I, Rodriguez-Fontenla C, Gomez-Reino JJ, et al. (2010) New sequence variants in HLA class II/III region associated with susceptibility to knee osteoarthritis identified by genome-wide association study. PLoS One 5: e9723.
16. Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH, et al. (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41: 1199-1206.
17. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, et al. (2008) Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358: 2355-2365.
18. Farber CR, (2010) Identification of a gene module associated with BMD through the integration of network analysis and genome-wide association data. J Bone Miner Res 25: 2359-2367.
19. Chung HW, Seo JS, Hur SE, Kim HL, Kim JY, et al. (2003) Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet 48: 243-248.
20. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL, (2003) Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88: 255-259.
21. Ferrari SL, Garnero P, Emond S, Montgomery H, Humphries SE, et al. (2001) A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum 44: 196-201.
22. Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH, (1997) Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 21: 89-92.
23. Swanberg M, McGuigan F, Ivaska KK, Gerdhem P, Lerner UH, et al. (2010) Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women. Bone 47: 424-429.
24. Weitzmann MN, Pacifici R, (2006) Estrogen regulation of immune cell bone interactions. Ann N Y Acad Sci 1068: 256-274.
25. Cenci S, Toraldo G, Weitzmann MN, Roggia C, Gao Y, et al. (2003) Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A 100: 10405-10410.
26. Bronson PG, Caillier S, Ramsay PP, McCauley JL, Zuvich RL, et al. (2010) CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Hum Mol Genet 19: 2331-2340.
27. Bronson PG, Goldstein BA, Ramsay PP, Beckman KB, Noble JA, et al. (2011) The rs4774 CIITA missense variant is associated with risk of systemic lupus erythematosus. Genes Immun.
28. Grunewald J, Idali F, Kockum I, Seddighzadeh M, Nisell M, et al. (2010) Major histocompatibility complex class II transactivator gene polymorphism: associations with Lofgren's syndrome. Tissue Antigens 76: 96-101.
29. Lindholm E, Melander O, Almgren P, Berglund G, Agardh CD, et al. (2006) Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality. PLoS One 1: e64.
30. Martinez A, Alvarez-Lafuente R, Mas A, Bartolome M, Garcia-Montojo M, et al. (2007) Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA. Hum Immunol 68: 685-689.
31. Martinez A, Perdigones N, Cenit MC, Espino L, Varade J, et al. (2010) Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis 69: 309-311.
32. Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, et al. (2008) Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 93: 3310-3317.
33. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, et al. (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37: 486-494.
34. Geijtenbeek TB, Gringhuis SI, (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9: 465-479.
35. Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, et al. (2007) A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448: 591-594.
36. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851-862.
37. Marquez A, Varade J, Robledo G, Martinez A, Mendoza JL, et al. (2009) Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients. Eur J Hum Genet 17: 1304-1308.
38. Zuvich RL, Bush WS, McCauley JL, Beecham AH, De Jager PL, et al. (2011) Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex. Hum Mol Genet.
39. Kim K, Cho SK, Sestak A, Namjou B, Kang C, et al. (2010) Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus. Ann Rheum Dis 69: 1247-1250.
40. Deguchi K, Kamada M, Irahara M, Maegawa M, Yamamoto S, et al. (2001) Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause 8: 266-273.
41. Gerdhem P, Brandstrom H, Stiger F, Obrant K, Melhus H, et al. (2004) Association of the collagen type 1 (COL1A 1) Sp1 binding site polymorphism to femoral neck bone mineral density and wrist fracture in 1044 elderly Swedish women. Calcif Tissue Int 74: 264-269.
42. McGuigan FE, Larzenius E, Callreus M, Gerdhem P, Luthman H, et al. (2007) Variation in the BMP2 gene: bone mineral density and ultrasound in young adult and elderly women. Calcif Tissue Int 81: 254-262.
43. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV, (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61: 863-866.
44. Morrison BA, Ucisik-Akkaya E, Flores H, Alaez C, Gorodezky C, et al. (2010) Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk. Autoimmunity 43: 690-697.
45. Lenora J, Akesson K, Gerdhem P, (2010) Effect of precision on longitudinal follow-up of bone mineral density measurements in elderly women and men. J Clin Densitom 13: 407-412.
46. Lenora J, Ivaska KK, Obrant KJ, Gerdhem P, (2007) Prediction of bone loss using biochemical markers of bone turnover. Osteoporos Int 18: 1297-1305.
47. Karlsson MK, Obrant KJ, Nilsson BE, Johnell O, (1998) Bone mineral density assessed by quantitative ultrasound and dual energy X-ray absorptiometry. Normative data in Malmo, Sweden. Acta Orthop Scand 69: 189-193.
48. Gerdhem P, Akesson K, (2007) Rates of fracture in participants and non-participants in the Osteoporosis Prospective Risk Assessment study. J Bone Joint Surg Br 89: 1627-1631.
49. Ivaska KK, Gerdhem P, Vaananen HK, Akesson K, Obrant KJ, (2010) Bone turnover markers and prediction of fracture: a prospective follow-up study of 1040 elderly women for a mean of 9 years. J Bone Miner Res 25: 393-403.
50. Ivaska KK, Lenora J, Gerdhem P, Akesson K, Vaananen HK, et al. (2008) Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab 93: 2622-2632.
51. Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, et al. (2001) Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides. Clin Chem 47: 1410-1414.
52. Seibel MJ, (2006) Biochemical Markers of Bone Turnover Part II: Clinical Applications in the Management of Osteoporosis. Clin Biochem Rev 27: 123-138.
53. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
54. Weusten JJ, Blankenstein MA, Gmelig-Meyling FH, Schuurman HJ, Kater L, et al. (1986) Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol (Copenh) 112: 409-414.
55. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, et al. (2009) A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41: 527-534.
56. Duncan EL, Danoy P, Kemp JP, Leo PJ, McCloskey E, et al. (2011) Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet 7: e1001372.
57. Guo Y, Tan LJ, Lei SF, Yang TL, Chen XD, et al. (2010) Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis. PLoS Genet 6: e1000806.
58. Guo Y, Zhang LS, Yang TL, Tian Q, Xiong DH, et al. (2010) IL21R and PTH may underlie variation of femoral neck bone mineral density as revealed by a genome-wide association study. J Bone Miner Res 25: 1042-1048.
59. Hsu YH, Zillikens MC, Wilson SG, Farber CR, Demissie S, et al. (2010) An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits. PLoS Genet 6: e1000977.
60. Karasik D, Hsu YH, Zhou Y, Cupples LA, Kiel DP, et al. (2010) Genome-wide pleiotropy of osteoporosis-related phenotypes: the Framingham Study. J Bone Miner Res 25: 1555-1563.
61. Koller DL, Ichikawa S, Lai D, Padgett LR, Doheny KF, et al. (2010) Genome-wide association study of bone mineral density in premenopausal European-American women and replication in African-American women. J Clin Endocrinol Metab 95: 1802-1809.
62. Kung AW, Xiao SM, Cherny S, Li GH, Gao Y, et al. (2010) Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am J Hum Genet 86: 229-239.
63. Paternoster L, Lorentzon M, Vandenput L, Karlsson MK, Ljunggren O, et al. (2010) Genome-wide association meta-analysis of cortical bone mineral density unravels allelic heterogeneity at the RANKL locus and potential pleiotropic effects on bone. PLoS Genet 6: e1001217.
64. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, et al. (2009) New sequence variants associated with bone mineral density. Nat Genet 41: 15-17.
65. Timpson NJ, Tobias JH, Richards JB, Soranzo N, Duncan EL, et al. (2009) Common variants in the region around Osterix are associated with bone mineral density and growth in childhood. Hum Mol Genet 18: 1510-1517.
66. Xiong DH, Liu XG, Guo YF, Tan LJ, Wang L, et al. (2009) Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet 84: 388-398.
67. Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM, et al. (2007) Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 8Suppl 1: S14.
68. Kou I, Takahashi A, Urano T, Fukui N, Ito H, et al. (2011) Common variants in a novel gene, FONG on chromosome 2q33.1 confer risk of osteoporosis in Japanese. PLoS One 6: e19641.
69. Liu YZ, Pei YF, Liu JF, Yang F, Guo Y, et al. (2009) Powerful bivariate genome-wide association analyses suggest the SOX6 gene influencing both obesity and osteoporosis phenotypes in males. PLoS One 4: e6827.
70. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, et al. (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371: 1505-1512.
71. Zhao LJ, Liu XG, Liu YZ, Liu YJ, Papasian CJ, et al. (2010) Genome-wide association study for femoral neck bone geometry. J Bone Miner Res 25: 320-329.
72. Kim JH, Kim K, Youn BU, Jin HM, Kim N, (2010) MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. Cell Signal 22: 1341-1349.
73. Awata T, Kawasaki E, Tanaka S, Ikegami H, Maruyama T, et al. (2009) Association of type 1 diabetes with two Loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J Clin Endocrinol Metab 94: 231-235.
74. Wu X, Zhu X, Wang X, Ma J, Zhu S, et al. (2009) Intron polymorphism in the KIAA0350 gene is reproducibly associated with susceptibility to type 1 diabetes (T1D) in the Han Chinese population. Clin Endocrinol (Oxf) 71: 46-49.
75. Zoledziewska M, Costa G, Pitzalis M, Cocco E, Melis C, et al. (2009) Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun 10: 15-17.
76. Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, et al. (2008) Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun 9: 624-630.